ORDER ONLINE FOR INSTANT ACCESS        
Search:
homecourse contentcurrent volumeback volumessubscribecontact usfaq

AUDIO WILL STREAM THROUGH ANY DEVICE
« Previous IssueNext Issue »


All subscribers to ACOG UPDATE audio CDs will also have free access and ability to download the same program in MP3 format. They can also download a PDF file of the complete transcript with Pre- and Post-test Questions and a List of Supplementary Reading Materials.

Volume 41, Issue 3
Publication date: September 1, 2015
Expiration date: September 1, 2018

Menopause--An Update
Robert L. Barbieri, MD (Moderator)
Kate Macy Ladd Professor of Obstetrics, Gynecology, and Reproductive Biology, Harvard Medical School; Chief of Obstetrics and Gynecology, Brigham and Women’s Hospital, Boston, Massachusetts

Kathryn A. Martin, MD
Assistant Professor of Medicine, Harvard Medical School; Reproductive Endocrine Unit, Massachusetts General Hospital, Boston; Senior Deputy Editor, UpToDate

Jan L. Shifren, MD
Associate Professor of Obstetrics, Gynecology, and Reproductive Biology, Harvard Medical School; Director, Midlife Women’s Health Center, Massachusetts General Hospital, Boston, Massachusetts; Immediate Past President, The North American Menopause Society

Learning Objectives
After completing this activity, the physician should be better able to:
1. Balance the risks and benefits of hormone therapy for the treatment of menopausal symptoms in women with complex medical problems.
2. Prescribe regimens of estrogen-progestin, estrogen-only, and progestin-only hormone therapy that maximize the benefits of treatment and minimize the risks.
3. Describe the differences in venous thromboembolism risk with oral and nonoral estrogen therapy.
4. Avoid prescribing hormone therapy to women with a personal history of breast or endometrial cancer.
5. Describe how the timing hypothesis influences the risk of hormone therapy.


Email Address

Password

Forgot my password
Not registered?
Click here to Sign-up
Listen, Learn and Earn